No Data
No Data
RBC Capital Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Cuts Target Price to $692
J.P. Morgan's Top Healthcare Stocks for 2025
China Neurogenomics Market Research 2024-2031, Profiles of Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, MGI Tech, Agilent, Revvity, Qiagen, Pacific Biosciences, Danaher, Oxford Nanopore - ResearchAndMarkets.com
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Intrinsic Value Is Potentially 56% Above Its Share Price
Express News | Thermo Fisher Scientific Inc : RBC Cuts Target Price to $692 From $711
loading...
No Data
Money Thrill : Very good overview and diversification